| Year |
Citation |
Score |
| 2023 |
Moreno-Estellés M, Campos-Rodríguez Á, Rubio-Villena C, Kumarasinghe L, Garcia-Gimeno MA, Sanz P. Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model. International Journal of Molecular Sciences. 24. PMID 37046993 DOI: 10.3390/ijms24076020 |
0.585 |
|
| 2021 |
Vela M, García-Gimeno MA, Sanchis A, Bono-Yagüe J, Cumella J, Lagartera L, Pérez C, Priego EM, Campos A, Sanz P, Vázquez-Manrique RP, Castro A. Neuroprotective Effect of IND1316, an Indole-Based AMPK Activator, in Animal Models of Huntington Disease. Acs Chemical Neuroscience. PMID 34962383 DOI: 10.1021/acschemneuro.1c00758 |
0.608 |
|
| 2021 |
Brewer MK, Machio-Castello M, Viana R, Wayne JL, Kuchtová A, Simmons ZR, Sternbach S, Li S, García-Gimeno MA, Serratosa JM, Sanz P, Vander Kooi CW, Gentry MS. An empirical pipeline for personalized diagnosis of Lafora disease mutations. Iscience. 24: 103276. PMID 34755096 DOI: 10.1016/j.isci.2021.103276 |
0.596 |
|
| 2021 |
Kumarasinghe L, Xiong L, Garcia-Gimeno MA, Lazzari E, Sanz P, Meroni G. TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases. Cells. 10. PMID 33917450 DOI: 10.3390/cells10040820 |
0.609 |
|
| 2020 |
Perez-Jimenez E, Viana R, Muñoz-Ballester C, Vendrell-Tornero C, Moll-Diaz R, Garcia-Gimeno MA, Sanz P. Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease. Glia. PMID 33368637 DOI: 10.1002/glia.23956 |
0.598 |
|
| 2020 |
Sanz P, Garcia-Gimeno MA. Reactive Glia Inflammatory Signaling Pathways and Epilepsy. International Journal of Molecular Sciences. 21. PMID 32521797 DOI: 10.3390/ijms21114096 |
0.528 |
|
| 2020 |
Espinós C, Galindo MI, García-Gimeno MA, Ibáñez-Cabellos JS, Martínez-Rubio D, Millán JM, Rodrigo R, Sanz P, Seco-Cervera M, Sevilla T, Tapia A, Pallardó FV. Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration. Antioxidants (Basel, Switzerland). 9. PMID 32326494 DOI: 10.3390/antiox9040313 |
0.54 |
|
| 2019 |
Sanchis A, García-Gimeno MA, Cañada-Martínez AJ, Sequedo MD, Millán JM, Sanz P, Vázquez-Manrique RP. Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease. Experimental & Molecular Medicine. 51: 65. PMID 31165723 DOI: 10.1038/s12276-019-0264-9 |
0.622 |
|
| 2018 |
García-Gimeno MA, Knecht E, Sanz P. Lafora Disease: A Ubiquitination-Related Pathology. Cells. 7. PMID 30050012 DOI: 10.3390/cells7080087 |
0.647 |
|
| 2018 |
Garcia-Gimeno MA, Rodilla-Ramirez PN, Viana R, Salas-Puig X, Brewer MK, Gentry MS, Sanz P. A novel EPM2A mutation yields a slow progression form of Lafora disease. Epilepsy Research. 145: 169-177. PMID 30041081 DOI: 10.1016/J.Eplepsyres.2018.07.003 |
0.631 |
|
| 2018 |
Sanz P, Viana R, Garcia-Gimeno MA. AMPK Protein Interaction Analyses by Yeast Two-Hybrid. Methods in Molecular Biology (Clifton, N.J.). 1732: 143-157. PMID 29480473 DOI: 10.1007/978-1-4939-7598-3_9 |
0.62 |
|
| 2018 |
Rubio-Villena C, Viana R, Bonet J, Garcia-Gimeno MA, Casado M, Heredia M, Sanz P. Astrocytes: new players in progressive myoclonus epilepsy of Lafora type. Human Molecular Genetics. PMID 29408991 DOI: 10.1093/hmg/ddy044 |
0.589 |
|
| 2017 |
Qian J, García-Gimeno MA, Beullens M, Manzione MG, Van der Hoeven G, Igual JC, Heredia M, Sanz P, Gelens L, Bollen M. An Attachment-Independent Biochemical Timer of the Spindle Assembly Checkpoint. Molecular Cell. 68: 715-730.e5. PMID 29129638 DOI: 10.1016/j.molcel.2017.10.011 |
0.586 |
|
| 2016 |
Sanz P, Viana R, Garcia-Gimeno MA. AMPK in Yeast: The SNF1 (Sucrose Non-fermenting 1) Protein Kinase Complex. Experientia Supplementum (2012). 107: 353-374. PMID 27812987 DOI: 10.1007/978-3-319-43589-3_14 |
0.629 |
|
| 2016 |
Sendra L, Miguel A, Pérez-Enguix D, Herrero MJ, Montalvá E, García-Gimeno MA, Noguera I, Díaz A, Pérez J, Sanz P, López-Andújar R, Martí-Bonmatí L, Aliño SF. Studying Closed Hydrodynamic Models of "In Vivo" DNA Perfusion in Pig Liver for Gene Therapy Translation to Humans. Plos One. 11: e0163898. PMID 27695064 DOI: 10.1371/journal.pone.0163898 |
0.522 |
|
| 2016 |
Oligschlaeger Y, Miglianico M, Dahlmans V, Rubio-Villena C, Chanda D, García-Gimeno MA, Coumans WA, Liu Y, Voncken JW, Luiken JJ, Glatz JF, Sanz P, Neumann D. The interaction between AMPKβ2 and the PP1-targeting subunit R6 is dynamically regulated by intracellular glycogen content. The Biochemical Journal. PMID 26831516 DOI: 10.1042/BJ20151035 |
0.616 |
|
| 2015 |
Rubio-Villena C, Sanz P, Garcia-Gimeno MA. Structure-Function Analysis of PPP1R3D, a Protein Phosphatase 1 Targeting Subunit, Reveals a Binding Motif for 14-3-3 Proteins which Regulates its Glycogenic Properties. Plos One. 10: e0131476. PMID 26114292 DOI: 10.1371/journal.pone.0131476 |
0.611 |
|
| 2013 |
Sanz P, Rubio T, Garcia-Gimeno MA. AMPKβ subunits: more than just a scaffold in the formation of AMPK complex. The Febs Journal. 280: 3723-33. PMID 23721051 DOI: 10.1111/febs.12364 |
0.623 |
|
| 2013 |
Rubio-Villena C, Garcia-Gimeno MA, Sanz P. Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex. The International Journal of Biochemistry & Cell Biology. 45: 1479-88. PMID 23624058 DOI: 10.1016/j.biocel.2013.04.019 |
0.622 |
|
| 2012 |
Garcia-Haro L, Garcia-Gimeno MA, Neumann D, Beullens M, Bollen M, Sanz P. Glucose-dependent regulation of AMP-activated protein kinase in MIN6 beta cells is not affected by the protein kinase A pathway. Febs Letters. 586: 4241-7. PMID 23116618 DOI: 10.1016/j.febslet.2012.10.032 |
0.614 |
|
| 2010 |
Garcia-Haro L, Garcia-Gimeno MA, Neumann D, Beullens M, Bollen M, Sanz P. The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 beta cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 5080-91. PMID 20724523 DOI: 10.1096/fj.10-166306 |
0.645 |
|
| 2009 |
Barbetti F, Cobo-Vuilleumier N, Dionisi-Vici C, Toni S, Ciampalini P, Massa O, Rodriguez-Bada P, Colombo C, Lenzi L, Garcia-Gimeno MA, Bermudez-Silva FJ, Rodriguez de Fonseca F, Banin P, Aledo JC, Baixeras E, et al. Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene. Molecular Endocrinology (Baltimore, Md.). 23: 1983-9. PMID 19884385 DOI: 10.1210/me.2009-0094 |
0.605 |
|
| 2008 |
Riera A, Ahuatzi D, Herrero P, Garcia-Gimeno MA, Sanz P, Moreno F. Human pancreatic beta-cell glucokinase: subcellular localization and glucose repression signalling function in the yeast cell. The Biochemical Journal. 415: 233-9. PMID 18588509 DOI: 10.1042/BJ20080797 |
0.568 |
|
| 2008 |
Estalella I, Garcia-Gimeno MA, Marina A, Castaño L, Sanz P. Biochemical characterization of novel glucokinase mutations isolated from Spanish maturity-onset diabetes of the young (MODY2) patients. Journal of Human Genetics. 53: 460-6. PMID 18322640 DOI: 10.1007/s10038-008-0271-5 |
0.595 |
|
| 2007 |
Lesage B, Beullens M, Pedelini L, Garcia-Gimeno MA, Waelkens E, Sanz P, Bollen M. A complex of catalytically inactive protein phosphatase-1 sandwiched between Sds22 and inhibitor-3. Biochemistry. 46: 8909-19. PMID 17630778 DOI: 10.1021/bi7003119 |
0.606 |
|
| 2007 |
Pedelini L, Marquina M, Ariño J, Casamayor A, Sanz L, Bollen M, Sanz P, Garcia-Gimeno MA. YPI1 and SDS22 proteins regulate the nuclear localization and function of yeast type 1 phosphatase Glc7. The Journal of Biological Chemistry. 282: 3282-92. PMID 17142459 DOI: 10.1074/jbc.M607171200 |
0.646 |
|
| 2005 |
Pedelini L, Garcia-Gimeno MA, Marina A, Gomez-Zumaquero JM, Rodriguez-Bada P, López-Enriquez S, Soriguer FC, Cuesta-Muñoz AL, Sanz P. Structure-function analysis of the alpha5 and the alpha13 helices of human glucokinase: description of two novel activating mutations. Protein Science : a Publication of the Protein Society. 14: 2080-6. PMID 15987895 DOI: 10.1110/ps.051485205 |
0.582 |
|
| 2004 |
Cuesta-Muñoz AL, Huopio H, Otonkoski T, Gomez-Zumaquero JM, Näntö-Salonen K, Rahier J, López-Enriquez S, García-Gimeno MA, Sanz P, Soriguer FC, Laakso M. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes. 53: 2164-8. PMID 15277402 DOI: 10.2337/diabetes.53.8.2164 |
0.621 |
|
| 2003 |
García-Gimeno MA, Muñoz I, Ariño J, Sanz P. Molecular characterization of Ypi1, a novel Saccharomyces cerevisiae type 1 protein phosphatase inhibitor. The Journal of Biological Chemistry. 278: 47744-52. PMID 14506263 DOI: 10.1074/jbc.M306157200 |
0.636 |
|
| Show low-probability matches. |